Date: June 22, 2017, 1 PM – 6:30 PM

Location: Shanghai, China

Register here.

The Marketing Authorization Holder System in China will expedite market access to the world’s second largest pharmaceutical economy, by allowing license holders of a drug to sell in China using a contract manufacturer. Ultimately, this policy will boost access to a large population and enable a shorter time to market for innovative drugs..

The symposium, co-hosted by Shanghai Municipal Food and Drug Administration, Shanghai Jinshan District People’s Government, and STA Pharmaceutical, a WuXi AppTec company, will provide a forum to hear the latest policy updates, share experience and discuss best-practices.

Keynote speakers from CFDA, UF FDA, and Shanghai Municipal FDA will provide an in depth overview and a panel of senior industry and regulatory leaders will discuss the opportunities, case studies, and answer questions.

Don’t miss this opportunity.